New COVID-19 drug shows greater promise against resistant viral strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee
Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...
INDY Week9h
A Chapel Hill Lab Faces New Threats Five Years After Covid-19
Public health leaders looked to UNC-Chapel Hill virologist Ralph Baric to end the pandemic. Their critics blamed it on him.
24/7 Wall St. on MSN12h
Wall Street Says Sell US Market Rallies: Never Sell These 4 High-Yield Dividend Giants
The "buy the dip" strategy worked flawlessly for over two years. Any significant drop in the stock market led to a sharp ...
Pandemic disruptions linked to lower TB diagnoses in prisons worldwide
A new study found that reported diagnoses for tuberculosis were consistently lower than expected throughout the pandemic, even though incarceration rates remained largely consistent and TB detection ...